Cyclic nucleotide phosphodiesterases
[摘要] Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal transduction and regulation of physiologic responses. Their intracellular levels are controlled by the complex superfamily of cyclic nucleotide phosphodiesterase (PDE) enzymes. Continuing advances in our understanding of the molecular pharmacology of these enzymes has led to the development of selective inhibitors as therapeutic agents for disease states ranging from cancer and heart failure to depression and sexual dysfunction. Several PDE types have been identified as therapeutic targets for immune/inflammatory diseases. This article briefly reviews the available in vitro, preclinical, and clinical data supporting the potential for selective PDE inhibitors as immunomodulatory agents.
[发布日期] 2001-11-01 [发布机构]
[效力级别] [学科分类]
[关键词] cyclic AMP;cyclic GMP;cyclic nucleotide phosphodiesterase;immunosuppression;inflammation [时效性]